Cargando…
Treatment of amyloidosis: present and future
Cardiac amyloidosis (CA) is an infiltrative heart disease resulting from the deposition of amyloid fibrils in the interstitial spaces of the myocardium. The two main forms of CA are represented by light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) in the two forms familial or variant...
Autores principales: | Mallus, Maria Teresa, Rizzello, Vittoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120969/ https://www.ncbi.nlm.nih.gov/pubmed/37091663 http://dx.doi.org/10.1093/eurheartjsupp/suad082 |
Ejemplares similares
-
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023) -
Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022) -
The treatment of amyloidosis is being refined
por: Cantone, Anna, et al.
Publicado: (2022) -
How much does hypertension in pregnancy affect the risk of future cardiovascular events?
por: Mureddu, Gian Francesco
Publicado: (2023) -
How much does the presentation pattern of atrial fibrillation affect thrombo-embolic risk and mortality?
por: Turturiello, Dario, et al.
Publicado: (2023)